In this issue:
Radionuclide treatment for mCRPC
Resource use in metastatic prostate cancer
Time to testosterone rebound and comorbidity in prostate cancer
Bone health in men receiving ADT
Guideline: anticancer therapy in metastatic non-castrate prostate cancer
QoL during treatment with chemo-hormonal therapy
Blood glucose, glycaemic control and prostate cancer risk
Costs of screening for prostate cancer
Focal irreversible electroporation for localised prostate cancer
Docetaxel vs surveillance after radical prostatectomy
Please login below to download this issue (PDF)